Fostamatinib - a prodrug of the active compound tamatinib which is an inhibitor of the enzyme spleen tyrosine kinase (Syk). It is a target for the inhibition of various autoimmune conditions and potentially used for the treatment of rheumatoid arthritis, lymphoma, and other autoimmune disease.








